Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 26

Trial Status

Completed2
Recruiting1
Terminated1
Other4

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT05645380Phase 2Active Not Recruiting
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
Breast CancerTriple Negative Breast Cancer
PrincipalinvestigatorStart date: 2022-12-05
NCT05143229Phase 1Active Not Recruiting
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
Breast Cancer
PrincipalinvestigatorStart date: 2022-03-28
NCT02393794Phase 1/2Active Not Recruiting
Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
Breast CancerTriple-Negative Breast Cancer
PrincipalinvestigatorStart date: 2015-07-17
NCT02379247Phase 1/2Completed
BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer
Breast Cancer
PrincipalinvestigatorStart date: 2015-02-01
NCT02302742Recruiting
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Breast CancerHereditary Breast and Ovarian Cancer
PrincipalinvestigatorStart date: 2011-03-22
NCT02413320Phase 2Completed
Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer
Triple-negative Breast Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT05645380Phase 2PrincipalInvestigator

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

Breast CancerTriple Negative Breast Cancer
Active Not Recruiting
NCT05143229Phase 1PrincipalInvestigator

Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer

Breast Cancer
Active Not Recruiting
NCT02393794Phase 1/2PrincipalInvestigator

Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)

Breast CancerTriple-Negative Breast Cancer
Active Not Recruiting
NCT02379247Phase 1/2PrincipalInvestigator

BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer

Breast Cancer
Completed
NCT02302742PrincipalInvestigator

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Breast CancerHereditary Breast and Ovarian Cancer
Recruiting
NCT00759642Phase 2PrincipalInvestigator

Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy

Metastatic Breast Cancer
Terminated
NCT01163929Phase 2PrincipalInvestigator

A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer

Breast Cancer
Withdrawn
NCT02413320Phase 2PrincipalInvestigator

Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer

Triple-negative Breast Cancer
Completed

All 8 trials loaded